Catalyst
Slingshot members are tracking this event:
Jazz Pharma Top-line results from the Phase 3 TONES Studies of JZP-110 in Treatment of Excessive Sleepiness in Adults with Obstructive Sleep Apnea
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JAZZ |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 20, 2017
Occurred Source:
http://investor.jazzpharma.com/phoenix.zhtml?c=210227&p=irol-newsArticle&ID=2255192
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Zp-110, Tones 3, Tones 4, Osa, Obstructive Sleep Apnea
